Transfusion

Cover image for Vol. 47 Issue 8

August 2007

Volume 47, Issue 8

Pages 1335–1559

  1. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
  2. EDITORIALS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
  3. CLINICAL RESEARCH FOCUS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. The science of systematic reviews (pages 1347–1349)

      Donald M. Arnold

      Article first published online: 6 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01324.x

  4. IMMUNOHEMATOLOGY

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. Effective molecular RHD typing strategy for blood donations (pages 1350–1355)

      Helene Polin, Martin Danzer, Katja Hofer, Waltraud Gassner and Christian Gabriel

      Article first published online: 1 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01278.x

    2. A DOB allele encoding an amino acid substitution (Phe62Ser) resulting in a Dombrock null phenotype (pages 1356–1362)

      Connie Westhoff, Sunitha Vege, Karina Yazdanbakhsh, Dwane Wylie, Mohammad Razib, Kim Hue-Roye, Gregory Halverson, Sandy Read, Elizabeth Whiteoak, Pam Nickle, Joan Maurer, Donna Kavitsky, Sandra Nance and Marion E. Reid

      Article first published online: 7 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01279.x

    3. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads (pages 1363–1368)

      Tamam Bakchoul, Oliver Meyer, Ashraf Agaylan, Stephane Bombard, Gregor Bein, Ulrich J.H. Sachs, Abdulgabar Salama and Sentot Santoso

      Article first published online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01274.x

  5. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-β1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I (pages 1395–1404)

      Luciano Ottonello, Massimo Ghio, Paola Contini, Maria Bertolotto, Giordano Bianchi, Fabrizio Montecucco, Marco Colonna, Clemente Mazzei, Franco Dallegri and Franco Indiveri

      Article first published online: 2 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01268.x

    2. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature (pages 1405–1411)

      Kemal Agbaht, Neriman Defne Altintas, Arzu Topeli, Ozay Gokoz and Osman Ozcebe

      Article first published online: 7 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01282.x

    3. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A (pages 1412–1417)

      Shealynn B. Harris, Cassandra D. Josephson, Christine B. Kost and Christopher D. Hillyer

      Article first published online: 1 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01283.x

    4. Detection of misfolded prion protein in blood with conformationally sensitive peptides (pages 1418–1425)

      Tao Pan, Jasmeet Sethi, Craig Nelsen, Alan Rudolph, Larisa Cervenakova, Paul Brown and Cindy S. Orser

      Article first published online: 25 JUL 2007 | DOI: 10.1111/j.1537-2995.2007.01284.x

  6. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. Two steps to functional mesenchymal stromal cells for clinical application (pages 1426–1435)

      Christina Bartmann, Eva Rohde, Katharina Schallmoser, Peter Pürstner, Gerhard Lanzer, Werner Linkesch and Dirk Strunk

      Article first published online: 3 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01219.x

    2. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells (pages 1436–1446)

      Katharina Schallmoser, Christina Bartmann, Eva Rohde, Andreas Reinisch, Karl Kashofer, Elke Stadelmeyer, Camilla Drexler, Gerhard Lanzer, Werner Linkesch and Dirk Strunk

      Article first published online: 3 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01220.x

    3. Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP (pages 1447–1454)

      Min Kyoung Kim, Shin Kim, Sung Sook Lee, Sun Jin Sym, Dae Ho Lee, Sang We Kim, Seongsoo Jang, Chan Jeong Park, Hyun Sook Chi, Jooryung Huh and Cheolwon Suh

      Article first published online: 1 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01285.x

  7. TRANSFUSION PRACTICE

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease (pages 1455–1467)

      Lorna M. Williamson, Dorothy Stainsby, Hilary Jones, Elizabeth Love, Catherine E. Chapman, Cristina Navarrete, Geoff Lucas, Cynthia Beatty, Angela Casbard, Hannah Cohen and the Serious Hazards of Transfusion Steering Group

      Article first published online: 1 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01281.x

    2. Blood use in elective surgery: the Austrian benchmark study (pages 1468–1480)

      Hans Gombotz, Peter H. Rehak, Aryeh Shander and Axel Hofmann

      Article first published online: 7 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01286.x

    3. Evaluation of nonleukoreduced red blood cell transfusion units collected at delivery from the placenta (pages 1481–1487)

      Line Widing, Anne Grete Bechensteen, Mohammad Reza Mirlashari, Annette Vetlesen and Jens Kjeldsen-Kragh

      Article first published online: 7 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01287.x

    4. Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia (pages 1488–1493)

      Juergen Ringwald, Michael Schroth, Florian Faschingbauer, Julian Strobel, Erwin Strasser, Ralf L. Schild and Tamme W. Goecke

      Article first published online: 7 JUN 2007 | DOI: 10.1111/j.1537-2995.2007.01288.x

  8. HEMAPHERESIS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning (pages 1494–1502)

      Nina Worel, Hildegard T. Greinix, Volker Supper, Gerda Leitner, Margit Mitterbauer, Werner Rabitsch, Gottfried Fischer, Agathe Rosenmayr, Paul Höcker and Peter Kalhs

      Article first published online: 29 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01289.x

  9. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
  10. IMMUNE HEMATOLOGIC DISEASE

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. HPA-13bw neonatal alloimmune thrombocytopenia and low frequency alloantigens: case report and review of the literature (pages 1510–1513)

      Gerald Bertrand, Frederic Bianchi, Marie Alexandre, Jeannine Quesne, Christophe Chenet, Corinne Martageix, Vincent Jallu and Cecile Kaplan

      Article first published online: 29 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01291.x

  11. BLOOD DONORS AND BLOOD DONATION

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. The consequences of temporary deferral on future whole blood donation (pages 1514–1523)

      Brian Custer, Artina Chinn, Nora V. Hirschler, Michael P. Busch and Edward L. Murphy

      Article first published online: 29 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01292.x

    2. The effect of a 473-mL (16-oz) water drink on vasovagal donor reaction rates in high-school students (pages 1524–1533)

      Bruce Newman, Emily Tommolino, Christina Andreozzi, Sonia Joychan, Jelena Pocedic and Julie Heringhausen

      Article first published online: 29 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01293.x

  12. BLOOD COMPONENTS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. In vivo recovery of human platelets in severe combined immunodeficient mice as a measure of platelet damage (pages 1540–1549)

      John T. Piper, Monique P. Gelderman and Jaroslav G. Vostal

      Article first published online: 29 MAY 2007 | DOI: 10.1111/j.1537-2995.2007.01295.x

  13. LETTERS TO THE EDITOR

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. Should cellular therapy products be tested for human herpesvirus 8? (page 1550)

      Jean-Jacques Lefrère, Nicolas Guillaume and Syria Laperche

      Article first published online: 25 JUL 2007 | DOI: 10.1111/j.1537-2995.2007.01350.x

    2. Time and temperature before processing influence the recovery of umbilical cord blood hematopoietic progenitors (pages 1550–1552)

      Nikos Tsagias, Kokkona Kouzi-Koliakos, Vassilios Karagiannis, Daryoush Hamidi Alamdari and George Koliakos

      Article first published online: 25 JUL 2007 | DOI: 10.1111/j.1537-2995.2007.01351.x

    3. Platelet activation during storage of platelet concentrates processed from buffy coats by the automated OrbiSac system (pages 1555–1556)

      Luis Larrea González, Maria Isabel Oritiz De Salazar, Roberto Roig and Maria Angeles Soler

      Article first published online: 25 JUL 2007 | DOI: 10.1111/j.1537-2995.2007.01354.x

  14. CORRECTIONS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIALS
    4. CLINICAL RESEARCH FOCUS
    5. IMMUNOHEMATOLOGY
    6. TRANSFUSION COMPLICATIONS
    7. TRANSPLANTATION AND CELLULAR ENGINEERING
    8. TRANSFUSION PRACTICE
    9. HEMAPHERESIS
    10. BLOOD CONSERVATION AND TRANSFUSION ALTERNATIVES
    11. IMMUNE HEMATOLOGIC DISEASE
    12. BLOOD DONORS AND BLOOD DONATION
    13. BLOOD COMPONENTS
    14. LETTERS TO THE EDITOR
    15. CORRECTIONS
    1. You have free access to this content
      CORRECTION (page 1558)

      Article first published online: 25 JUL 2007 | DOI: 10.1111/j.1537-2995.2007.01431.x

      This article corrects:
    2. You have free access to this content
      CORRECTION (page 1559)

      Article first published online: 25 JUL 2007 | DOI: 10.1111/j.1537-2995.2007.01442.x

      This article corrects:

SEARCH

SEARCH BY CITATION